ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 74 filers reported holding ADMA BIOLOGICS INC in Q3 2019. The put-call ratio across all filers is 3.79 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $2,090,174 | +36.1% | 316,693 | -6.8% | 0.00% | +100.0% |
| Q4 2023 | $1,535,218 | +26.1% | 339,650 | -0.1% | 0.00% | 0.0% |
| Q3 2023 | $1,217,770 | -17.3% | 340,159 | -14.8% | 0.00% | 0.0% |
| Q2 2023 | $1,473,004 | +90.7% | 399,188 | +71.0% | 0.00% | 0.0% |
| Q1 2023 | $772,597 | -10.7% | 233,413 | +4.6% | 0.00% | 0.0% |
| Q4 2022 | $865,496 | +28749.9% | 223,066 | +20845.2% | 0.00% | – |
| Q3 2022 | $3,000 | – | 1,065 | +1070.3% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 91 | -99.7% | 0.00% | – |
| Q3 2021 | $40,000 | +25.0% | 35,000 | +91.0% | 0.00% | – |
| Q1 2021 | $32,000 | +14.3% | 18,328 | +25.2% | 0.00% | – |
| Q4 2020 | $28,000 | -48.1% | 14,634 | +20.3% | 0.00% | – |
| Q3 2019 | $54,000 | – | 12,162 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 883,214 | $1,722,000 | 0.80% |
| Telemetry Investments, L.L.C. | 200,615 | $391,000 | 0.66% |
| Perceptive Advisors | 16,584,802 | $32,340,000 | 0.35% |
| Consonance Capital Management LP | 1,558,290 | $3,039,000 | 0.28% |
| 683 Capital Management, LLC | 2,000,000 | $3,900,000 | 0.18% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 627,931 | $1,224,000 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 327,052 | $638,000 | 0.10% |
| APOGEM CAPITAL LLC | 54,240 | $106,000 | 0.07% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 82,000 | $160,000 | 0.04% |
| J. Goldman & Co LP | 376,319 | $734,000 | 0.04% |